Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-21

Clinical Trial Update: Food and Relative Bioavailability Study [Phase 1]

View source ↗

Summary

Phase 1 study update on food effect and relative bioavailability sponsored by GlaxoSmithKline for a depressive disorder indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED